Patient
SITE007-0004
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2025-08-25
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-03-30
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-09-23 (study day 204); relationship: not assessed
mild
assessed
2025-12-27
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-06-22 (study day 111); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.